Medipharm Labs Corp Stock Price History

LABS Stock  CAD 0.07  0.01  7.14%   
Below is the normalized historical share price chart for Medipharm Labs Corp extending back to February 14, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medipharm Labs stands at 0.07, as last reported on the 13th of December 2024, with the highest price reaching 0.07 and the lowest price hitting 0.06 during the day.
200 Day MA
0.0728
50 Day MA
0.0704
Beta
0.921
 
Covid
If you're considering investing in Medipharm Stock, it is important to understand the factors that can impact its price. Medipharm Labs appears to be out of control, given 3 months investment horizon. Medipharm Labs Corp has Sharpe Ratio of 0.0502, which conveys that the firm had a 0.0502% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Medipharm Labs, which you can use to evaluate the volatility of the firm. Please exercise Medipharm Labs' Risk Adjusted Performance of 0.0288, downside deviation of 7.68, and Mean Deviation of 4.01 to check out if our risk estimates are consistent with your expectations.
  
At this time, Medipharm Labs' Total Stockholder Equity is very stable compared to the past year. As of the 13th of December 2024, Common Stock Shares Outstanding is likely to grow to about 381.5 M, while Other Stockholder Equity is likely to drop 0.00. . As of the 13th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 0.68. Medipharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0502

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsLABS
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.7
  actual daily
50
50% of assets are less volatile

Expected Return

 0.29
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Medipharm Labs is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medipharm Labs by adding it to a well-diversified portfolio.
Price Book
0.6388
Enterprise Value Ebitda
(1.82)
Price Sales
0.7622
Shares Float
382.2 M
Wall Street Target Price
0.1

Medipharm Labs Stock Price History Chart

There are several ways to analyze Medipharm Stock price data. The simplest method is using a basic Medipharm candlestick price chart, which shows Medipharm Labs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 21, 20240.08
Lowest PriceSeptember 24, 20240.065

Medipharm Labs December 13, 2024 Stock Price Synopsis

Various analyses of Medipharm Labs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Medipharm Stock. It can be used to describe the percentage change in the price of Medipharm Labs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Medipharm Stock.
Medipharm Labs Price Daily Balance Of Power(1.00)
Medipharm Labs Accumulation Distribution 96,214 
Medipharm Labs Price Rate Of Daily Change 0.93 

Medipharm Labs December 13, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Medipharm Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Medipharm Labs intraday prices and daily technical indicators to check the level of noise trading in Medipharm Stock and then apply it to test your longer-term investment strategies against Medipharm.

Medipharm Stock Price History Data

The price series of Medipharm Labs for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 has a statistical range of 0.02 with a coefficient of variation of 6.38. The daily prices for the period are spread out with arithmetic mean of 0.07. The median price for the last 90 days is 0.07. The company underwent 1:2 stock split on 4th of October 2018.
OpenHighLowCloseVolume
12/12/2024 0.07  0.07  0.06  0.07  1,250,784 
12/11/2024 0.07  0.07  0.07  0.07  25,680 
12/10/2024 0.07  0.07  0.07  0.07  124,960 
12/09/2024 0.07  0.07  0.07  0.07  45,181 
12/06/2024 0.07  0.07  0.07  0.07  36,337 
12/05/2024 0.07  0.07  0.07  0.07  114,201 
12/04/2024 0.07  0.07  0.07  0.07  239,444 
12/03/2024 0.07  0.07  0.07  0.07  145,100 
12/02/2024 0.07  0.07  0.07  0.07  48,289 
11/29/2024 0.07  0.07  0.07  0.07  50,792 
11/28/2024 0.07  0.07  0.07  0.07  55,100 
11/27/2024 0.07  0.07  0.07  0.07  189,100 
11/26/2024 0.07  0.07  0.07  0.07  105,300 
11/25/2024 0.07  0.07  0.07  0.07  158,443 
11/22/2024 0.07  0.07  0.07  0.07  260,909 
11/21/2024 0.07  0.07  0.07  0.07  144,500 
11/20/2024 0.07  0.07  0.07  0.07  47,100 
11/19/2024 0.07  0.07  0.07  0.07  148,600 
11/18/2024 0.07  0.07  0.07  0.07  48,400 
11/15/2024 0.07  0.07  0.07  0.07  143,313 
11/14/2024 0.07  0.07  0.07  0.07  733,709 
11/13/2024 0.07  0.08  0.07  0.08  374,568 
11/12/2024 0.07  0.08  0.07  0.07  691,372 
11/11/2024 0.07  0.07  0.07  0.07  450,333 
11/08/2024 0.07  0.07  0.07  0.07  227,588 
11/07/2024 0.07  0.07  0.07  0.07  280,600 
11/06/2024 0.07  0.07  0.07  0.07  582,700 
11/05/2024 0.07  0.07  0.07  0.07  322,800 
11/04/2024 0.07  0.07  0.07  0.07  75,000 
11/01/2024 0.07  0.07  0.07  0.07  39,950 
10/31/2024 0.07  0.07  0.07  0.07  54,756 
10/30/2024 0.07  0.07  0.07  0.07  18,535 
10/29/2024 0.07  0.07  0.07  0.07  677,552 
10/28/2024 0.07  0.08  0.07  0.07  204,300 
10/25/2024 0.08  0.08  0.07  0.07  29,328 
10/24/2024 0.07  0.08  0.07  0.07  231,200 
10/23/2024 0.07  0.08  0.07  0.08  14,397 
10/22/2024 0.08  0.08  0.07  0.07  264,579 
10/21/2024 0.07  0.08  0.07  0.08  705,200 
10/18/2024 0.07  0.08  0.07  0.07  389,462 
10/17/2024 0.07  0.07  0.07  0.07  85,523 
10/16/2024 0.07  0.07  0.07  0.07  370,472 
10/15/2024 0.07  0.07  0.07  0.07  29,800 
10/11/2024 0.07  0.07  0.07  0.07  69,657 
10/10/2024 0.07  0.07  0.07  0.07  114,550 
10/09/2024 0.07  0.07  0.07  0.07  93,200 
10/08/2024 0.07  0.07  0.07  0.07  210,960 
10/07/2024 0.07  0.07  0.07  0.07  236,100 
10/04/2024 0.07  0.07  0.07  0.07  285,481 
10/03/2024 0.07  0.07  0.07  0.07  210,200 
10/02/2024 0.07  0.07  0.07  0.07  36,663 
10/01/2024 0.07  0.07  0.07  0.07  46,198 
09/30/2024 0.07  0.07  0.07  0.07  59,890 
09/27/2024 0.07  0.07  0.07  0.07  141,528 
09/26/2024 0.07  0.07  0.07  0.07  206,189 
09/25/2024 0.07  0.07  0.07  0.07  156,759 
09/24/2024 0.07  0.07  0.07  0.07  335,623 
09/23/2024 0.07  0.07  0.07  0.07  91,600 
09/20/2024 0.07  0.07  0.07  0.07  47,217 
09/19/2024 0.07  0.07  0.07  0.07  121,949 
09/18/2024 0.07  0.07  0.07  0.07  84,768 

About Medipharm Labs Stock history

Medipharm Labs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medipharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medipharm Labs Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medipharm Labs stock prices may prove useful in developing a viable investing in Medipharm Labs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding363.3 M381.5 M
Net Loss-27 M-28.3 M

Medipharm Labs Quarterly Net Working Capital

25.74 Million

Medipharm Labs Stock Technical Analysis

Medipharm Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medipharm Labs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medipharm Labs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Medipharm Labs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Medipharm Labs' price direction in advance. Along with the technical and fundamental analysis of Medipharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medipharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Medipharm Stock

Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.